Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis
- PMID: 6823561
- DOI: 10.1126/science.6823561
Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis
Abstract
Four persons developed marked parkinsonism after using an illicit drug intravenously. Analysis of the substance injected by two of these patients revealed primarily 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) with trace amounts of 1-methyl-4-phenyl-4-propionoxy-piperidine (MPPP). On the basis of the striking parkinsonian features observed in our patients, and additional pathological data from one previously reported case, it is proposed that this chemical selectively damages cells in the substantia nigra.
Similar articles
-
Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.Psychiatry Res. 1979 Dec;1(3):249-54. doi: 10.1016/0165-1781(79)90006-4. Psychiatry Res. 1979. PMID: 298352
-
Parkinsonism induced with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cats: behavioral, biochemical and pathological studies.Chin Med Sci J. 1993 Dec;8(4):223-6. Chin Med Sci J. 1993. PMID: 8032069
-
Progression and recovery of Parkinsonism in a chronic progressive MPTP-induction model in the marmoset without persistent molecular and cellular damage.Neuroscience. 2016 Jan 15;312:247-59. doi: 10.1016/j.neuroscience.2015.09.065. Epub 2015 Oct 9. Neuroscience. 2016. PMID: 26431624
-
[Significance of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine for the etiology and therapy of idiopathic Parkinson disease].Fortschr Neurol Psychiatr. 1989 Apr;57(4):142-8. doi: 10.1055/s-2007-1000755. Fortschr Neurol Psychiatr. 1989. PMID: 2656447 Review. German.
-
Biochemical mechanisms underlying MPTP-induced and idiopathic parkinsonism. New vistas.Adv Neurol. 1993;60:300-5. Adv Neurol. 1993. PMID: 8380523 Review. No abstract available.
Cited by
-
Human midbrain organoids: a powerful tool for advanced Parkinson's disease modeling and therapy exploration.NPJ Parkinsons Dis. 2024 Oct 20;10(1):189. doi: 10.1038/s41531-024-00799-8. NPJ Parkinsons Dis. 2024. PMID: 39428415 Free PMC article. Review.
-
Hypoxia Pathways in Parkinson's Disease: From Pathogenesis to Therapeutic Targets.Int J Mol Sci. 2024 Sep 29;25(19):10484. doi: 10.3390/ijms251910484. Int J Mol Sci. 2024. PMID: 39408813 Free PMC article. Review.
-
A comprehensive review of natural compounds and their structure-activity relationship in Parkinson's disease: exploring potential mechanisms.Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct 11. doi: 10.1007/s00210-024-03462-4. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 39392484 Review.
-
Discovery of hybrid Glypromate conjugates with neuroprotective activity against paraquat-induced toxicity.RSC Med Chem. 2024 Aug 26. doi: 10.1039/d4md00584h. Online ahead of print. RSC Med Chem. 2024. PMID: 39290380 Free PMC article.
-
CHCHD2 mutant mice display mitochondrial protein accumulation and disrupted energy metabolism.bioRxiv [Preprint]. 2024 Aug 31:2024.08.30.610586. doi: 10.1101/2024.08.30.610586. bioRxiv. 2024. PMID: 39257750 Free PMC article. Preprint.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical